title: Venous thromboembolism in cancer patients: risk assessment, prevention and management.
abstract: Thrombosis and thromboembolic events contribute to significant morbidity in cancer patients. Venous thrombosis embolism (which includes deep vein thrombosis and pulmonary embolism) accounts for a large percentage of thromboembolic events. Appropriate identification of cancer patients at high risk for venous thromboembolism and management of thromboembolic event is crucial in improving the quality of care for cancer patients. However, thromboembolism in cancer patients is a complex problem and the management has to be tailored to each individual. The focus of this review is to understand the complex pathology, physiology and risk factors that drive the process of venous thrombosis and embolism in cancer patients and the current guidelines in management.
authors.affiliation: Department of Medicine/Division of Cardiovascular Medicine, The Ohio State University, 473 W 12th Ave, #200, Columbus, OH 43210, USA.
authors.forename: Deepali N
authors.initials: DN
authors.lastname: Tukaye
authors.affiliation: College of Pharmacy, The Ohio State University, 500 W 12th Ave, #217, Columbus, OH 43210, USA.
authors.forename: Heidi
authors.initials: H
authors.lastname: Brink
authors.affiliation: Department of Medicine/Division of Cardiovascular Medicine, The Ohio State University, 473 W 12th Ave, #200, Columbus, OH 43210, USA.
authors.forename: Ragavendra
authors.initials: R
authors.lastname: Baliga
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D018570:Risk Assessment; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*
keywords: VTE prevention; guidelines-based VTE management; risk stratification; thrombosis in cancer patients